13:17 , Mar 9, 2017 |  BC Week In Review  |  Financial News

Airway Therapeutics completes venture financing

On March 6, lung disease company Airway Therapeutics LLC (Cincinnati, Ohio) raised $6.3 million in a venture financing with new investors and existing investors Cincinnati Children’s Hospital Medical Center, CincyTech and Queen City Angels. Airway Therapeutics...
07:00 , Sep 22, 2014 |  BC Week In Review  |  Financial News

Airway Therapeutics completes venture financing

Airway Therapeutics LLC, Cincinnati, Ohio   Business: Pulmonary   Date completed: 2014-09-10   Type: Venture financing   Raised: $4.6 million   Investors: CincyTech; Cincinnati Children's Hospital Medical Center; Queen City Angels; private investors   ...
07:00 , Mar 12, 2012 |  BioCentury  |  Emerging Company Profile

Airway: Pulmonary D-fense

Products containing surfactant proteins B and C have reduced mortality caused by respiratory distress syndrome in premature newborns, but chronic bronchopulmonary dysplasia caused by ventilation remains a problem. Airway Therapeutics LLC has shown adding surfactant...
07:00 , Jun 13, 2011 |  BC Week In Review  |  Financial News

Airway Therapeutics completes venture financing

Airway Therapeutics LLC, Cincinnati, Ohio   Business: Pulmonary   Date completed: 6/3/11   Type: Venture financing   Raised: $500,000   Investors: CincyTech; Cincinnati Children's Tomorrow Fund   ...
07:00 , Jun 13, 2011 |  BC Week In Review  |  Company News

Airway Therapeutics, Cincinnati Children's Hospital Medical Center pulmonary news

Cincinnati Children's Hospital granted newco Airway Therapeutics an exclusive, worldwide license to commercialize pulmonary therapy research conducted at the hospital, including preclinical recombinant human surfactant protein D (rhSP-D). Airway will initially focus on developing rhSP-D...